M.D.C. Stock Price, News & Analysis (NYSE:MDC)

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

M.D.C. announced a quarterly dividend on Monday, July 22nd. Shareholders of record on Wednesday, August 7th will be paid a dividend of $0.30 per share on Wednesday, August 21st. This represents a $1.20 dividend on an annualized basis and a yield of 2.62%. The ex-dividend date is Tuesday, August 6th. View M.D.C.'s Dividend History.

M.D.C. Holdings, Inc. (NYSE:MDC) issued its quarterly earnings data on Wednesday, July, 31st. The construction company reported $0.86 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.78 by $0.08. The construction company earned $732.84 million during the quarter, compared to analysts' expectations of $727.20 million. M.D.C. had a net margin of 6.64% and a return on equity of 13.24%. The firm's revenue was down 2.2% compared to the same quarter last year. During the same quarter last year, the business earned $1.03 EPS. View M.D.C.'s Earnings History.

M.D.C. is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for M.D.C..

M.D.C. will be holding an earnings conference call on Wednesday, October 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

4 Wall Street analysts have issued 1-year price targets for M.D.C.'s stock. Their forecasts range from $31.00 to $49.00. On average, they expect M.D.C.'s share price to reach $40.33 in the next twelve months. This suggests that the stock has a possible downside of 11.9%. View Analyst Price Targets for M.D.C..

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 2 hold ratings, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for M.D.C..

News coverage about MDC stock has trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. M.D.C. earned a daily sentiment score of -1.7 on InfoTrie's scale. They also gave headlines about the construction company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for M.D.C..

M.D.C. saw a increase in short interest in the month of September. As of September 15th, there was short interest totalling 2,050,000 shares, an increase of 6.2% from the August 15th total of 1,930,000 shares. Based on an average daily volume of 490,300 shares, the days-to-cover ratio is currently 4.2 days. Approximately 4.2% of the shares of the stock are sold short. View M.D.C.'s Current Options Chain.

Some companies that are related to M.D.C. include D. R. Horton (DHI), Lennar (LEN), NVR (NVR), PulteGroup (PHM), Toll Brothers (TOL), KB Home (KBH), Meritage Homes (MTH), TRI Pointe Group (TPH), Cavco Industries (CVCO), M/I Homes (MHO), Beazer Homes USA (BZH), Hovnanian Enterprises (HOV) and Ryland Group (RYL).

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Bank of Hawaii (BOH), InterDigital Wireless (IDCC), Stag Industrial (STAG), Procter & Gamble (PG), Celgene (CELG), Intel (INTC), Ford Motor (F), Cisco Systems (CSCO), Gilead Sciences (GILD) and Micron Technology (MU).

M.D.C.'s stock is owned by many different of retail and institutional investors. Top institutional shareholders include Hamlin Capital Management LLC (2.76%), Strs Ohio (0.53%), Smith Graham & Co. Investment Advisors LP (0.50%), Bowling Portfolio Management LLC (0.08%), Nisa Investment Advisors LLC (0.08%) and State of Alaska Department of Revenue (0.06%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker and Robert Nathaniel Martin. View Institutional Ownership Trends for M.D.C..

MDC stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio, Hamlin Capital Management LLC, Carroll Financial Associates Inc., Alpha Windward LLC, Nisa Investment Advisors LLC and First Hawaiian Bank. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker and Robert Nathaniel Martin. View Insider Buying and Selling for M.D.C..

MDC stock was bought by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC, Denali Advisors LLC, State of Alaska Department of Revenue, Fox Run Management L.L.C., Stephens Inc. AR, Campbell & CO Investment Adviser LLC, Private Vista LLC and First Citizens Bank & Trust Co.. View Insider Buying and Selling for M.D.C..

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MDC stock can currently be purchased for approximately $45.76.

M.D.C. has a market capitalization of $2.84 billion and generates $2.98 billion in revenue each year. The construction company earns $210.78 million in net income (profit) each year or $3.67 on an earnings per share basis. M.D.C. employs 1,581 workers across the globe.View Additional Information About M.D.C..

The official website for M.D.C. is http://www.mdcholdings.com/.

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]